miRNA-21, an Important Regulator of Autoimmune Diseases
View abstract on PubMed
Summary
This summary is machine-generated.MicroRNA-21 (miRNA-21), a key regulator in cells, is implicated in the development of autoimmune diseases like multiple sclerosis and lupus. This study investigates its pathogenic role in autoimmune illness.
Area Of Science
- Immunology
- Molecular Biology
- Genetics
Background
- MicroRNA-21 (miRNA-21) is abundant and conserved, playing critical regulatory roles in cellular functions.
- miRNA-21 is implicated in the pathogenesis of various immune-related and autoimmune disorders.
- Autoimmune diseases such as Multiple Sclerosis and Systemic Lupus Erythematosus are examples where miRNA-21 may play a role.
Purpose Of The Study
- To investigate the specific role of miRNA-21 in the development of autoimmune diseases.
- To understand the pathogenic significance of miRNA-21 in the context of autoimmune illness.
Main Methods
- The study focused on analyzing the role of miRNA-21.
- Investigated miRNA-21 as a pathogenic factor in autoimmune disease development.
Main Results
- miRNA-21 is identified as a significant pathogenic microRNA.
- The research highlights miRNA-21's involvement in the progression of autoimmune conditions.
Conclusions
- miRNA-21 is a crucial factor in the pathogenesis of autoimmune diseases.
- Further research into miRNA-21's mechanisms could lead to new therapeutic strategies for autoimmune disorders.
Related Concept Videos
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

